These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2718604)

  • 1. Experimental polyvalent ISCOMs subunit vaccine induces antibodies that neutralize human and bovine respiratory syncytial virus.
    Trudel M; Nadon F; Séguin C; Simard C; Lussier G
    Vaccine; 1989 Feb; 7(1):12-6. PubMed ID: 2718604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant subunit vaccine for bovine RSV and Histophilus somni protects calves against dual pathogen challenge.
    Gershwin LJ; Behrens NE; McEligot HA; Carvallo-Chaigneau FR; Crum LT; Gunnarson BM; Corbeil LB
    Vaccine; 2017 Apr; 35(15):1954-1963. PubMed ID: 28274639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection.
    Hancock GE; Speelman DJ; Frenchick PJ; Mineo-Kuhn MM; Baggs RB; Hahn DJ
    Vaccine; 1995 Mar; 13(4):391-400. PubMed ID: 7793137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing response of rabbits to an experimental rubella subunit vaccine made from immunostimulating complexes.
    Trudel M; Nadon F; Séguin C; Payment P
    Can J Microbiol; 1988 Dec; 34(12):1351-4. PubMed ID: 3233560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
    Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
    Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bovine ephemeral fever vaccine incorporating adjuvant Quil A: a comparative study using adjuvants Quil A, aluminium hydroxide gel and dextran sulphate.
    Vanselow BA; Abetz I; Trenfield K
    Vet Rec; 1985 Jul; 117(2):37-43. PubMed ID: 2412334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140.
    Fulton RW; Confer AW; Burge LJ; Perino LJ; d'Offay JM; Payton ME; Mock RE
    Vaccine; 1995; 13(8):725-33. PubMed ID: 7483787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine.
    Trudel M; Nadon F; Séguin C; Brault S; Lusignan Y; Lemieux S
    Vaccine; 1992; 10(2):107-12. PubMed ID: 1539463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine leukaemia virus ISCOMs: biochemical characterization.
    Merza MS; Linné T; Höglund S; Portetelle D; Burny A; Morein B
    Vaccine; 1989 Feb; 7(1):22-8. PubMed ID: 2541575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of rabbits with a bovine herpesvirus type 1 subunit vaccine: adjuvant effect of ISCOMs.
    Trudel M; Nadon F; Seguin C; Boulay G; Lussier G
    Vaccine; 1987 Sep; 5(3):239-43. PubMed ID: 2823496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.
    Stittelaar KJ; Boes J; Kersten GF; Spiekstra A; Mulder PG; de Vries P; Roholl PJ; Dalsgaard K; van den Dobbelsteen G; van Alphen L; Osterhaus AD
    Vaccine; 2000 May; 18(23):2482-93. PubMed ID: 10775782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silica vesicles as nanocarriers and adjuvants for generating both antibody and T-cell mediated immune resposes to Bovine Viral Diarrhoea Virus E2 protein.
    Mody KT; Mahony D; Zhang J; Cavallaro AS; Zhang B; Popat A; Mahony TJ; Yu C; Mitter N
    Biomaterials; 2014 Dec; 35(37):9972-9983. PubMed ID: 25239045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
    Schmidt AC; Wenzke DR; McAuliffe JM; St Claire M; Elkins WR; Murphy BR; Collins PL
    J Virol; 2002 Feb; 76(3):1089-99. PubMed ID: 11773385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
    Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field trials on a live bovine respiratory syncytial virus vaccine in calves.
    Kubota M; Fukuyama S; Takamura K; Izumida A; Kodama K
    J Vet Med Sci; 1992 Oct; 54(5):957-62. PubMed ID: 1420579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
    Liu X; Liang B; Ngwuta J; Liu X; Surman S; Lingemann M; Kwong PD; Graham BS; Collins PL; Munir S
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies.
    Garg R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Vaccine; 2015 Mar; 33(11):1338-44. PubMed ID: 25637860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant varicella vaccine harboring a respiratory syncytial virus gene induces humoral immunity.
    Murakami K; Matsuura M; Ota M; Gomi Y; Yamanishi K; Mori Y
    Vaccine; 2015 Nov; 33(45):6085-92. PubMed ID: 26116253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.